United Theranostics Appoints Rob Cherney as CEO to Lead Its Radiopharmaceutical Therapy and Supportive Molecular Imaging Business
Minneapolis, MN, September 17, 2024 – United Theranostics Parent, LLC (“United Theranostics” or the “Company”), a leader in radiopharmaceutical therapy and supportive molecular imaging for cancer treatment, is pleased to announce the appointment of Rob Cherney as its new Chief Executive Officer.